1. Home
  2. JDZG vs DVAX Comparison

JDZG vs DVAX Comparison

Compare JDZG & DVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JDZG
  • DVAX
  • Stock Information
  • Founded
  • JDZG 2020
  • DVAX 1996
  • Country
  • JDZG China
  • DVAX United States
  • Employees
  • JDZG N/A
  • DVAX N/A
  • Industry
  • JDZG Other Consumer Services
  • DVAX Biotechnology: Pharmaceutical Preparations
  • Sector
  • JDZG Real Estate
  • DVAX Health Care
  • Exchange
  • JDZG Nasdaq
  • DVAX Nasdaq
  • Market Cap
  • JDZG 7.0M
  • DVAX 1.3B
  • IPO Year
  • JDZG 2024
  • DVAX 2004
  • Fundamental
  • Price
  • JDZG $2.09
  • DVAX $9.36
  • Analyst Decision
  • JDZG
  • DVAX Buy
  • Analyst Count
  • JDZG 0
  • DVAX 4
  • Target Price
  • JDZG N/A
  • DVAX $26.50
  • AVG Volume (30 Days)
  • JDZG 146.9K
  • DVAX 1.9M
  • Earning Date
  • JDZG 04-25-2025
  • DVAX 11-06-2025
  • Dividend Yield
  • JDZG N/A
  • DVAX N/A
  • EPS Growth
  • JDZG N/A
  • DVAX N/A
  • EPS
  • JDZG 0.25
  • DVAX N/A
  • Revenue
  • JDZG $2,567,741.00
  • DVAX $316,268,000.00
  • Revenue This Year
  • JDZG N/A
  • DVAX $23.23
  • Revenue Next Year
  • JDZG N/A
  • DVAX $16.57
  • P/E Ratio
  • JDZG $8.27
  • DVAX N/A
  • Revenue Growth
  • JDZG 20.36
  • DVAX 26.66
  • 52 Week Low
  • JDZG $1.58
  • DVAX $9.21
  • 52 Week High
  • JDZG $21.28
  • DVAX $14.63
  • Technical
  • Relative Strength Index (RSI)
  • JDZG 52.10
  • DVAX 32.99
  • Support Level
  • JDZG $1.65
  • DVAX $9.51
  • Resistance Level
  • JDZG $2.30
  • DVAX $9.94
  • Average True Range (ATR)
  • JDZG 0.22
  • DVAX 0.29
  • MACD
  • JDZG 0.06
  • DVAX -0.07
  • Stochastic Oscillator
  • JDZG 67.69
  • DVAX 12.31

About JDZG JIADE LIMITED Common stock

Jiade Ltd specializes in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platform and auxiliary solutions. Auxiliary solutions encompass exam administration services and teaching support services throughout the entire teaching cycle. Specifically, the company offers pre-enrollment guidance on school/major selection and application strategy development, training for entrance exams, and assistance in the application process. The company also provides offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance included in the one-stop comprehensive education supporting services in the People's Republic of China.

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Share on Social Networks: